Fund Universe

ACUTA CAPITAL PARTNERS, LLC

CIK 0001582844 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.146
AUM ($M)
143
Positions
23
Turnover
0.32
Top-10 wt
74%
Herfindahl
0.088
History (qtrs)
6
Excess Return
not eligible

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 31 positions · portfolio value $143M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
PRAX funds › PRAXIS PRECISION MEDICINES I TRIM 19.3% -0.1% 27.7 82,796 -2,105 5
WHWK funds › WHITEHAWK THERAPEUTICS INC ADD Common Stock 15.0% +6.6% 21.5 4,685,912 +1,275,510 5
TNGX funds › TANGO THERAPEUTICS INC TRIM 8.5% +1.9% 12.2 390,949 -50,882 3
STRO funds › SUTRO BIOPHARMA INC ADD 6.3% +1.5% 9.0 270,251 +826 3
AVBP funds › ARRIVENT BIOPHARMA INC NEW 5.3% +5.3% 7.6 218,694 +218,694 1
FDMT funds › 4D MOLECULAR THERAPEUTICS INC NEW 4.7% +4.7% 6.8 507,801 +507,801 1
DRUG funds › BRIGHT MINDS BIOSCIENCES INC TRIM 4.5% -1.3% 6.5 92,745 -19,251 5
OCUL funds › OCULAR THERAPEUTIX INC TRIM 3.6% +0.1% 5.2 532,481 -59,627 5
ERAS funds › ERASCA INC TRIM 3.4% -0.7% 4.9 265,199 -89,376 2
SRZN funds › SURROZEN INC ADD 3.1% -0.4% 4.5 173,395 +548 5
ARGX funds › ARGEN SE - ADR ADD 3.0% +0.6% 4.4 4,705 +15 5
MLTX funds › MOONLAKE IMMUNOTHERAPEUTICS ADD 2.9% +0.4% 4.2 215,652 +23,892 3
DSGN funds › DESIGN THERAPEUTICS INC ADD 2.8% +1.7% 4.1 282,564 +136,664 3
NERV funds › MINERVA NEUROSCIENCES HOLD 2.7% -0.3% 3.9 709,500 +0 3
TSHA funds › TAYSHA GENE THERAPIES INC ADD 2.7% +1.3% 3.8 561,808 +122,344 5
AVLN funds › AVALYN PHARMA INC NEW 2.6% +2.6% 3.8 115,000 +115,000 1
AVTX funds › AVALO THERAPEUTICS INC ADD 2.4% +1.8% 3.4 186,308 +125,500 2
AMLX funds › AMYLYX PHARMACEUTICALS INC ADD 2.1% +0.6% 3.0 168,115 +17,048 4
ARTV funds › ARTIVA BIOTHERAPEUTICS INC NEW 1.8% +1.8% 2.5 260,416 +260,416 1
CMPX funds › COMPASS THERAPEUTICS INC TRIM 0.9% -2.3% 1.3 595,213 -253,863 4
UTHR funds › UNITED THERAPEUTICS CORP HOLD 0.8% -0.1% 1.2 2,224 +0 4
CTNM funds › CONTINEUM THERAPEUTICS INC-A NEW 0.7% +0.7% 1.0 63,095 +63,095 1
LBRX funds › LB PHARMACEUTICALS INC HOLD 0.7% +0.1% 0.9 28,919 +0 4
MAZE funds › MAZE THERAPEUTICS INC EXIT 0.0% -0.4% 0.0 0 -19,335 0
UNCY funds › UNICYCIVE THERAPEUTICS INC EXIT 0.0% -0.3% 0.0 0 -57,959 0
TRDA funds › ENTRADA THERAPEUTICS INC EXIT 0.0% -0.8% 0.0 0 -89,358 0
OCS funds › OCULIS HOLDING AG EXIT 0.0% -1.9% 0.0 0 -98,339 0
IDYA funds › IDEAYA BIOSCIENCES INC EXIT 0.0% -1.1% 0.0 0 -48,234 0
RVMD funds › REVOLUTION MEDICINES INC EXIT 0.0% -1.8% 0.0 0 -26,069 0
CUSIP:880881107 funds › TERNS PHARMACEUTICALS INC EXIT 0.0% -18.6% 0.0 0 -495,772 0
CUSIP:35104E104 funds › 4D MOLECULAR THERAPEUTICS INC EXIT 0.0% -1.6% 0.0 0 -242,255 0

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 143 23 0.32 74% 0.088 0.148 in
2026Q1 141 26 0.32 78% 0.099 0.184 in
2025Q4 147 30 0.36 79% 0.096 0.118 in
2025Q3 97 28 0.30 76% 0.079 0.129 in
2025Q2 72 28 0.27 72% 0.068 0.137 entered
2025Q1 86 34 0.00 65% 0.053 0.000 out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status